» Authors » Gema Jimenez

Gema Jimenez

Explore the profile of Gema Jimenez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 614
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Chocarro-Wrona C, De Vicente J, Antich C, Jimenez G, Martinez-Moreno D, Carrillo E, et al.
Bioeng Transl Med . 2021 Feb; 6(1):e10192. PMID: 33532591
Tissue engineering (TE) seeks to fabricate implants that mimic the mechanical strength, structure, and composition of native tissues. Cartilage TE requires the development of functional personalized implants with cartilage-like mechanical...
12.
Pisano A, Grinan-Lison C, Farace C, Fiorito G, Fenu G, Jimenez G, et al.
Cancers (Basel) . 2020 Nov; 12(11). PMID: 33227890
Colorectal cancer (CRC) is the third most frequent cancer worldwide and the second cause of cancer deaths. Increasing evidences supports the idea that the poor prognosis of patients is related...
13.
Mora-Boza A, Lopez-Ruiz E, Lopez-Donaire M, Jimenez G, Aguilar M, Marchal J, et al.
Polymers (Basel) . 2020 Nov; 12(11). PMID: 33187239
In the present study, semi- and interpenetrated polymer network (IPN) systems based on hyaluronic acid (HA) and chitosan using ionic crosslinking of chitosan with a bioactive crosslinker, glycerylphytate (GPhy), and...
14.
Jimenez G, Andres J, Marchal J
Adv Exp Med Biol . 2020 Oct; 1277:115-126. PMID: 33119869
The importance of the microenvironment in tumor development and their resistance to drugs is increasingly well known. This microenvironment is composed of different cell types, among which cells with stemness...
15.
Andres J, Grinan-Lison C, Jimenez G, Marchal J
J Hematol Oncol . 2020 Oct; 13(1):136. PMID: 33059744
Cancer stem cells (CSCs) represent a tumor subpopulation responsible for tumor metastasis and resistance to chemo- and radiotherapy, ultimately leading to tumor relapse. As a consequence, the detection and eradication...
16.
Hernandez-Camarero P, Amezcua-Hernandez V, Jimenez G, Garcia M, Marchal J, Peran M
Nanomedicine (Lond) . 2020 Sep; 15(23):2311-2324. PMID: 32969312
The use of nanotechnology has become a promising approach in the treatment of cancer. However, most intravenously injected nanoparticles (NPs) do not effectively reach the tumor mass due to the...
17.
Ortega-Garcia M, Mesa A, Moya E, Rueda B, Lopez-Ordono G, Garcia J, et al.
Cancers (Basel) . 2020 Feb; 12(2). PMID: 32045987
Colorectal cancer treatment has advanced over the past decade. The drug 5-fluorouracil is still used with a wide percentage of patients who do not respond. Therefore, a challenge is the...
18.
Antich C, De Vicente J, Jimenez G, Chocarro C, Carrillo E, Montanez E, et al.
Acta Biomater . 2020 Feb; 106:114-123. PMID: 32027992
Bioprinting is a promising tool to fabricate well-organized cell-laden constructs for repair and regeneration of articular cartilage. The selection of a suitable bioink, in terms of composition and mechanical properties,...
19.
Farace C, Pisano A, Grinan-Lison C, Solinas G, Jimenez G, Serra M, et al.
Oncotarget . 2020 Feb; 11(2):116-130. PMID: 32010426
Colorectal cancer (CRC) is a deadly tumour in Western countries characterized by high cellular/molecular heterogeneity. Cancer stem cells (CSC) act in cancer recurrence, drug-resistance and in metastatic epithelial-to-mesenchymal transition. microRNAs...
20.
Grinan-Lison C, Olivares-Urbano M, Jimenez G, Lopez-Ruiz E, Del Val C, Morata-Tarifa C, et al.
Mol Oncol . 2020 Jan; 14(3):556-570. PMID: 31930680
In breast cancer (BC), the presence of cancer stem cells (CSCs) has been related to relapse, metastasis, and radioresistance. Radiotherapy (RT) is an extended BC treatment, but is not always...